课题基金 / 基金详情

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
有限竞争:国家生物防护实验室 (NBL) 运营支持(不允许进行 UC7 临床试验)
批准号:
10634557
负责人:
Gary Kobinger
金额:
$1150.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-05-31 至 2026-05-31

项目摘要

项目成果

Gary Kobinger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract The goal of this project is to maintain the Galveston National Laboratory (GNL) at the University of Texas Medical Branch as a part of the NIAID Biodefense Facilities Network to provide access to maximum containment research facilities for NIAID funded investigators, academic collaborators from across the nation and around the world, commercial partners and others as appropriate. This high containment research infrastructure and associated facilities is required to safely and securely conduct research that will facilitate the discovery and development of therapeutics, diagnostics and vaccines for dangerous pathogens requiring biocontainment. This unique resource is also a critical resource to educate the next generation of experts in infectious diseases of global health importance. The GNL actively responds to national public health emergencies by providing rapid assistance in diagnostics, sharing of critical reagents, and contributing to the discovery and development of effective medical countermeasures. To achieve this goal, the GNL maintains cores focused on supporting safe and secure operations and maintenance of maximum containment research facilities and to provide unique resources and tools to investigators working in biocontainment to allow them to rapidly, safely and securely address emerging infectious diseases and bioterrorism threats. Unique capabilities include the ability to generate and quantify aerosol challenges of laboratory animals from mice to non-human primates, access to arthropod vector colonies to support zoonotic disease transmission studies, and state-of-the-art imaging capabilities to visualize findings, among many others. Working together, GNL teams conduct basic and applied research that can transition original discoveries from concept to final product development, validation and licensure.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1172/jci164946
发表时间: 2023-02-01
期刊: JOURNAL OF CLINICAL INVESTIGATION
影响因子: 15.9
作者: [Woolsey, Courtney, Borisevich, Viktoriya, Fears, Alyssa C., Agans, Krystle N., Deer, Daniel J., Prasad, Abhishek N., O'Toole, Rachel, Foster, Stephanie L., Dobias, Natalie S., Geisbert, Joan B., Fenton, Karla A., Cross, Robert W., Geisbert, Thomas W.]
通讯作者: Geisbert, Thomas W.
DOI: 10.3390/vaccines10101582
发表时间: 2022-09-21
期刊: Vaccines
影响因子: 7.8
作者: [Cooper CL, Morrow G, Yuan M, Coleman JW, Hou F, Reiserova L, Li SL, Wagner D, Carpov A, Wallace-Selman O, Valentin K, Choi Y, Wilson A, Kilianski A, Sayeed E, Agans KN, Borisevich V, Cross RW, Geisbert TW, Feinberg MB, Gupta SB, Parks CL]
通讯作者: Parks CL
A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
重组水泡性口炎病毒疫苗可提供针对本迪布焦埃博拉病毒感染的暴露后保护。
DOI: 10.1093/infdis/jiad207
发表时间: 2023
期刊: The Journal of infectious diseases
影响因子: --
作者: [Woolsey,Courtney, Strampe,Jamie, Fenton,KarlaA, Agans,KrystleN, Martinez,Jasmine, Borisevich,Viktoriya, Dobias,NatalieS, Deer,DanielJ, Geisbert,JoanB, Cross,RobertW, Connor,JohnH, Geisbert,ThomasW]
通讯作者: Geisbert,ThomasW
DOI: 10.1038/s41467-021-22132-0
发表时间: 2021-03-25
期刊: Nature communications
影响因子: 16.6
作者: [Cross RW, Bornholdt ZA, Prasad AN, Borisevich V, Agans KN, Deer DJ, Abelson DM, Kim DH, Shestowsky WS, Campbell LA, Bunyan E, Geisbert JB, Fenton KA, Zeitlin L, Porter DP, Geisbert TW]
通讯作者: Geisbert TW
23
    Pandemic Preparedness: Biocontainment Facility Upgrade and Integration at UTMB/Galveston National Laboratory
    Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
    Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
    海外基金